Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.65
-0.03 (-4.65%)
At close: Aug 20, 2025, 11:37 AM
Xilio Therapeutics Revenue
Xilio Therapeutics reported an annual revenue of $6.34M, reflecting a 0% growth. For the quarter ending June 30, 2025, Xilio Therapeutics generated $8.08M in revenue.
Revenue (ttm)
6.34M
Revenue Growth
n/a
Price / Sales Ratio
8.06
Revenue / Employee
99.13K
Employees
64
Market Cap
33.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 6.34M | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |